Position in LLY
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$6,325,794
+$1,993,678 QoQ
Shares Held
5,274
+12.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#1,535
of 4,605 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cooper Financial Group holds $19,451,562 across 11 Drug Manufacturers - General names. LLY ranks #1 (32.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,274 | $6,325,794 | |
| 2 | AMGN |
Amgen Inc
|
8,265 | $2,992,921 | |
| 3 | ABBV |
AbbVie Inc.
|
11,460 | $2,883,794 | |
| 4 | JNJ |
Johnson & Johnson
|
10,851 | $2,755,828 | |
| 5 | AZN |
Astrazeneca PLC
|
6,342 | $1,202,570 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,089 | $1,039,436 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,387 | $713,738 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,403 | $556,275 |
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,325,794 | 5,274 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $4,332,116 | 4,710 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $4,838,209 | 4,502 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $3,653,244 | 4,788 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $3,553,877 | 4,559 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $2,457,908 | 2,976 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,049,660 | 2,655 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,736,442 | 1,960 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,473,053 | 1,627 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,183,277 | 1,521 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $763,625 | 1,310 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $701,491 | 1,306 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $545,892 | 1,164 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $336,551 | 980 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $248,405 | 679 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $249,626 | 772 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $235,390 | 726 | Shares | Sole | 2022-07-11 | |
| No filing history on record for this holder in this stock. | ||||||